Effect of calcitriol combined with Kuntai capsule on serum monocyte chemotactic factor -1 and leptin and pregnancy rate of prognosis in patients with polycystic ovary syndrome

Abstract

Objective To investigate the application effect of calcitriol combined with Kuntai capsule in patients with polycystic ovary syndrome. Methods Ninety-seven cases with polycystic ovary syndrome were enrolled in the study and were randomly divided into two groups, 48 cases in the control group were given clomifene citrate capsules, and 49 cases in the observation group were treated with calcitriol combined with Kuntai capsule on the basis of the control group.The treatment effect, endometrial thickness, number of mature follicles, cervical mucus score and sex hormones (luteinizing hormone (LH), androgen, testosterone (T), follicle stimulating hormone (FSH), estradiol (E2)) before and after the treatment, the serum monocyte chemotactic factor -1 (MCP-1) and Leptin level of the two groups were observed and compared.And the rate of pregnancy and the incidence of adverse reactions were recorded. Results The total efficiency of the observation group was 95.92%(47/49), higher than that of the control group (79.17%(38/48))(χ2=6.277, P=0.012). The endometrial thickness, the number of mature follicles and the cervical mucus score of the observation group were significantly higher than those of the control group(t=4.978, 7.175, 7.387, P 0.05). Conclusion Calcitriol combined with Kuntai capsule can improve the serum MCP-1, Leptin levels and sex hormone levels in patients with polycystic ovary syndrome, and improve the prognosis of pregnancy rate.Besides, the effect is remarkable with high medication safety. Key words: Polycystic ovary syndrome; Calcitriol; Kuntai capsule; Serum monocyte chemotactic factor-1; Leptin